175 europeans travelling to different malaria endemic areas received either mefloquine alone ( 250 mg/week ) or its combination with sulfadoxine ( 500 mg/week ) plus pyrimethamine ( 25 mg/week ) .
C0024530
malaria
C0034283
pyrimethamine